5. Conclusion
Polypharmacy is common in both older and middle-aged people with
diabetes, with increasing trends in the study period, particularly in
patients between 55-64 years of age. Despite an increase in
polypharmacy, we observed a decrease in PIM prevalence in patients of 65
years and older with polypharmacy. No decrease was seen for middle-aged
patients with polypharmacy. The most common PIMs in people with diabetes
were similar to those seen in the general population. Further efforts
are needed to decrease the use of PIMs in populations already burdened
with many drugs.